Culley Brian M's Form 4 filing
Lineage Cell Therapeutics, Inc. (LCTX) · filed May 28, 2024
- Accession no.
- 0000950170-24-064896
- Filed
- May 28, 2024
- Trade date
- May 24, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $10.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Culley Brian MCIK 0001310683 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 24, 2024 | Common Shares | PPurchaseAcquired | +10,000 | $1.05 | +$10,500 | 154,842 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.